.
.; author, dr. barbara starfield, revered public health expert at the johns hopkins school of public health; �is us health really the best in the world?�
.
.
he added: �these findings show that despite the tireless work of doctors and nurses, it appears that some cancer patients are still enduring shockingly long waits to start treatment.
.
.
.
amb. macharia kamau
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
�now we know the astonishing truth that some patients are waiting a year or more just to get treatment. it�s simply not good enough.�
.
.